Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?

被引：10
|
作者：
Kulkarni, Amit A. [1 ]
Naqash, Abdul Rafeh [2 ]
Puri, Sonam [3 ]
Dienstmann, Rodrigo [4 ,5 ]
机构：
[1] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[2] NCI, Dev Therapeut Clin, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
[3] Huntsman Canc Inst, Div Oncol, Thorac Clin Trials Res Grp, Salt Lake City, UT USA
[4] Grp Oncoclin, Oncoclin Precis Med, Sao Paulo, Brazil
[5] Vall dHebron Inst Oncol, Oncol Data Sci Grp, P Vall dHebron 119-129, Barcelona 08035, Spain
来源：
JCO PRECISION ONCOLOGY | 2021年 / 5卷
关键词：
POSTOPERATIVE RADIOTHERAPY; PHASE-III; SOMATIC MUTATIONS; STAGE; CHEMOTHERAPY; GEFITINIB; SURVIVAL; CISPLATIN; OSIMERTINIB; CARCINOMAS;
D O I：
10.1200/PO.20.00460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：408 / 414
页数：7
相关论文
共 50 条
  • [1] Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer
    Wu, Fang
    Liu, Xianling
    Ma, Jin-an
    Gao, Yawen
    Hu, Chunhong
    [J]. LANCET ONCOLOGY, 2018, 19 (03): : E124 - E124
  • [2] Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer Reply
    Wu, Yi-Long
    Zhong, Wen-Zhao
    [J]. LANCET ONCOLOGY, 2018, 19 (03): : E127 - E127
  • [3] Adjuvant TKI therapy in resected EGFR-mutant non-small-cell lung cancer-ready for prime time?
    Arulananda, Surein
    John, Thomas
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 1728 - 1731
  • [4] Treatment choice in EGFR-mutant non-small-cell lung cancer
    Brueckl, Wolfgang M.
    [J]. LANCET ONCOLOGY, 2017, 18 (11): : 1425 - 1426
  • [5] Spontaneously expectorated EGFR-mutant non-small-cell lung cancer
    Sumi, Toshiyuki
    Terai, Kotomi
    Chiba, Hirofumi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (11) : 1094 - 1095
  • [6] What We Have Learned From Adjuvant Therapy for Resected EGFR-Mutant Non-Small-Cell Lung Cancer
    Liu, Si-Yang
    Zhang, Jia-Tao
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (03) : 217 - +
  • [7] Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer
    Cabanero, M.
    Tsao, M. S.
    [J]. CURRENT ONCOLOGY, 2018, 25 : S38 - S44
  • [8] Brain metastases in patients with EGFR-mutant non-small-cell lung cancer
    Rosell, Rafael
    Karachaliou, Niki
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (09): : 669 - 671
  • [9] Targeting MET amplification in EGFR-mutant non-small-cell lung cancer
    Rosell, Rafael
    Chaib, Imane
    Santarpia, Mariacarmela
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : 1068 - 1070
  • [10] Minimal residual disease in EGFR-mutant non-small-cell lung cancer
    Bain, Nathan T. T.
    Wang, Yang
    Arulananda, Surein
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345